Related Experiment Video
Updated: May 9, 2026
08:31
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
Recent developments in nanoparticle-based siRNA delivery for cancer therapy
Jong-Min Lee1, Tae-Jong Yoon, Young-Seok Cho
1Department of Internal Medicine, Uijeongbu St. Mary's Hospital, The Catholic University of Korea College of Medicine, Uijeongbu 480717, Republic of Korea.
Biomed Research International
|July 12, 2013
Summary
Small interfering RNA (siRNA) offers potential for treating genetic diseases by silencing specific genes. Nanoparticle delivery systems are advancing siRNA therapeutics, particularly for cancer treatment.
Area of Science:
- Biotechnology
- Molecular Biology
- Nanomedicine
Background:
- RNA interference (RNAi) is a natural gene regulation process.
- Small interfering RNA (siRNA) therapeutics target specific mRNA for gene silencing.
- Effective in vivo delivery and stability are key challenges for siRNA applications.
Purpose of the Study:
- Review recent advancements in nanoparticle-mediated siRNA delivery.
- Discuss the clinical applications of siRNA in cancer therapy.
- Provide perspectives on future directions for siRNA therapeutics.
Main Methods:
- Literature review of nanoparticle-mediated siRNA delivery systems.
- Analysis of current clinical trial data for siRNA cancer therapies.
- Synthesis of information on challenges and future prospects.
Main Results:
- Nanotechnology has yielded efficient siRNA delivery systems.
- siRNA therapeutics show promise in clinical trials for cancer.
- Overcoming delivery challenges is crucial for therapeutic success.
Conclusions:
- Nanoparticle-based delivery enhances siRNA stability and efficacy.
- siRNA holds significant therapeutic potential for genetic disorders and cancer.
- Continued research in delivery systems will expand siRNA applications.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...